OncoCyte Corp (OCX)

[pymadams]

My understanding of the progress so far and the plans for the future.
By the end of June this year (2019) they should have concluded all tests so they can proceed to commercialisation.
Reimbursement won't happen until insurance companies see studies showing that it made sense to test with OCX instead of doing a biopsy.

At an OCX presentation earlier in the year they said that they expect some insurance support by the middle of 2020. At the presentation yesterday they said the maximum number of sales reps they would have would be about 40 by 2021. That looks as though they expect to show that the tests save money/ less intrusive by this time and the effort is to get physicians and patients to request the test thru insurance.

It's not clear to me how the progress for the next year will actually work.
If I have a suspected lung cancer, will my Dr say "do you want a potentially dangerous lung biopsy for free or pay 3000 dollars for a test"?
If the tests work will the insurance companies be eager to get a fast adoption or do they make more money when the diagnosis is expensive?